News
Stay up to date with the latest milestones, announcements, and press coverage from Re:Pair Genomics.
Re:Pair Genomics Presents Poster at the Cell & Gene Therapy West Coast Symposium
On September 7, California Life Sciences and Johnson & Johnson Innovation co-hosted a West Coast Symposium focusing on Cell and Gene Therapy – Advancing…
In silico prediction and in vivo testing of promoters targeting GABAergic inhibitory neurons
Impairment of GABAergic inhibitory neuronal function is linked to epilepsy and other neurological and psychiatric disorders. Recombinant adeno-associated virus (rAAV)-based gene therapy targeting GABAergic…
Pitch Perfect 2022 Recap & Winners Announcement
On Wednesday November 9th, 2022, H2i welcomed founders, students, faculty, mentors and more to Pitch Perfect 2022! Marking H2i’s first in-person event since early…
Hatchery NEST 2022 Demo Day
Over 90% of gene therapy clinical trials fail at the moment. The reasons for failure include adverse effects and low efficacy of the treatment.…
Re:Pair Therapeutics Finalists
Finalists in Termis Americas Annual Conference and Exhibition